Dear Friends, The Epilepsy Therapy Project (ETP) is pleased to share with you this article from today’s New York Times. We are proud and deeply honored that Steve Wulchin is leading ETP’s SUDEP Task Force, and as you will see, Steve speaks...
Danny, Amber, and Zöe Dear Friends, With Father’s Day upon us, I have been thinking a lot about family, and how thankful I am to have my daughter and wife both present in my life. I am especially grateful for the research efforts that...
Epilepsy.com has a great section on antiepileptic drugs (AEDs), but I often have been asked for a brief summary document that pulls the information into one package. This summary represents the opinion of the author, Dr. Robert Fisher, who is an...
CDC highlights risks of H1N1 virus ("swine flu") for children with epilepsy. The Center for Disease Control in Atlanta announced that, as of 8/8/09, 477 people in the US died from H1N1 influenza (flu), including 36 children. Nearly 70%...
Vigabatrin (Sabril®) was approved on 8/21/09 by the US FDA for treatment of infantile spasms in children, and uncontrolled complex partial seizures in adults, according to Lundbeck, Inc., a pharmaceutical company. Vigabatrin is a "designer...

Pages